BN Business News
Add your company to Business Communicator →

Business · 20/07/1998Updated: 10/17/2026 · 1 min read

FDA Approves Injectable Dosage Form for Flunixin Meglumine

Summary

The FDA has approved a supplemental new animal drug application for Schering-Plough Animal Health Corp.'s flunixin meglumine solution, allowing its veterinary prescription use to control pyrexia and inflammation in beef and nonlactating dairy cattle.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →